887486-85-3

Upstream product

• 887486-83-1 1-[2,5-di-O-(tert-butyldimethylsilyl)-3-C-(2-mesyloxyethyl)-β-D-ribo-pentofuranosyl]uracil 
• 1666-13-3 diphenyl diselenide 
• 162611-11-2 1-[2-O-(tert-butyldimethylsilyl)-β-D-erythro-pentofuran-3-ulosyl]uracil 
• 186839-94-1 Bromo-acetic acid (2R,4S,5R)-4-(tert-butyl-dimethyl-silanyloxy)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3-oxo-tetrahydro-furan-2-ylmethyl ester 
• 186839-96-3 1-[(2R,3R,3aR,7aR)-3-(tert-Butyl-dimethyl-silanyloxy)-3a-hydroxy-5-oxo-hexahydro-furo[2,3-c]pyran-2-yl]-1H-pyrimidine-2,4-dione 
• 887486-79-5 1-[2,5-di-O-(tert-butyldimethylsilyl)-3-C-(methoxycarbonylmethyl)-β-D-ribo-pentofuranosyl]uracil 
• 887486-81-9 1-[2,5-di-O-(tert-butyldimethylsilyl)-3-C-(2-hydroxyethyl)-β-D-ribo-pentofuranosyl]uracil 

Relevant academic research and scientific papers

Synthesis of 3′-β-carbamoylmethylcytidine (CAMC) and its derivatives as potential antitumor agents

3′-β-Carbamoylmethylcytidine (CAMC) and its derivatives were synthesized using an intramolecular Reformatsky-type reaction promoted by SmI2 as the key step. In vitro tumor cell growth inhibitory activity was evaluated and CAMC was found to exhi